Immuron IMRN
NASDAQ IMRN
$1.80 +0.68 (+60.71%)
At close: Sep 4, 2026 · 4:00 PM EDT

Immuron (IMRN) Shares Outstanding (2015 - 2026)

Immuron (IMRN) posted Shares Outstanding (Entity) of $5.8 million for Q2 2025, up 2.61% on a QoQ basis from $5.7 million in Q2 2024, and up 2.61% year-over-year from $5.7 million in Q2 2024.

Analysis

Immuron (IMRN) Shares Outstanding (2015 - 2026) Analysis & Trends

Immuron has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $5.8 million in Q2 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 2.61% year-over-year to $5.8 million in Q2 2025; TTM through Jun 2025 was $5.8 million, a 2.61% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 2.61% from the prior year.
  • Shares Outstanding (Entity) was $5.8 million for Q2 2025 at Immuron, up from $5.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $5.8 million in Q2 2025, with the low at $5.7 million in Q2 2021.
  • Average Shares Outstanding (Entity) over 5 years is $5.7 million, with a median of $5.7 million recorded in 2022.
  • The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Entity) grew 27.47% in 2021, then changed 0.0% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $5.7 million in 2021, then grew by 0.24% to $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023, then gained by 0.09% to $5.7 million in 2024, then grew by 2.61% to $5.8 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $5.8 million (Q2 2025), $5.7 million (Q2 2024), and $5.7 million (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 61.30 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 133.61 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 147.70 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 217.35 Mn
10 Immuron 10.53 Mn 1.51 Mn - 5.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 5.77 Mn
Dec 31, 2025 5.77 Mn
Sep 2, 2025 5.77 Mn
Jun 30, 2025 5.77 Mn
Dec 31, 2024 5.70 Mn
Sep 9, 2024 5.70 Mn
Jun 30, 2024 5.70 Mn
Dec 31, 2023 5.69 Mn
Sep 28, 2023 5.69 Mn
Aug 30, 2023 5.69 Mn
Jun 30, 2023 5.69 Mn
Dec 31, 2022 5.69 Mn
Aug 31, 2022 5.69 Mn
Jun 30, 2022 5.69 Mn
Dec 31, 2021 5.53 Mn
Sep 30, 2021 5.53 Mn
Jun 30, 2021 5.53 Mn
Dec 31, 2020 4.41 Mn
Sep 1, 2020 4.41 Mn
Jun 30, 2020 4.41 Mn